Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4653 (miR-4653, specifically miR-4653-3p) is a small non-coding RNA molecule that regulates gene expression post-transcriptionally by binding to the 3'-untranslated regions of target messenger RNAs, leading to their degradation or translational repression. It is not a traditional therapeutic target such as a receptor or enzyme, but rather functions as a regulator in gene networks. Upregulation of miR-4653-3p has been linked to aggressive features and poor prognosis in pancreatic ductal adenocarcinoma, likely through direct downregulation of HIPK2, a tumor suppressor gene[1]. Expression alterations of miR-4653-3p occur in various tumors including breast cancer, glioblastoma, and nasopharyngeal carcinoma, and it plays a role in tumorigenesis, progression, and potential metastatic behavior[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4653 (miR-4653).